Nuestra experiencia con infliximab en psoriasis recalcitrante

Pereiro Jr, M; González-Vilas, D; Sánchez-Aguilar, D; Tor, J

array:17 ["pii" => "13125457" "issn" => "00017310" "estado" => "S300" "fechaPublicacion" => "2008-07-15" "documento" => "article" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2008;99 Supl 4:43-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1910 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 777 "PDF" => 1132 ] ] "itemAnterior" => array:14 [ "pii" => "13125456" "issn" => "00017310" "estado" => "S300" "fechaPublicacion" => "2008-07-15" "documento" => "article" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2008;99 Supl 4:36-42" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2137 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 715 "PDF" => 1421 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Experiencia personal con el uso de infliximab" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "36" "paginaFinal" => "42" ] ] "contieneResumen" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "G Carretero" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "G" "apellidos" => "Carretero" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13125456?idApp=UINPBA000044" "url" => "/00017310/00000099000000S4/v0_201507151025/13125456/v0_201507151025/es/main.assets" ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Nuestra experiencia con infliximab en psoriasis recalcitrante" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "43" "paginaFinal" => "47" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "M Pereiro Jr, D González-Vilas, D Sánchez-Aguilar, J Tor" "autores" => array:4 [ 0 => array:3 [ "Iniciales" => "M" "apellidos" => "Pereiro Jr" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] ] ] 1 => array:3 [ "Iniciales" => "D" "apellidos" => "González-Vilas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] ] ] 2 => array:3 [ "Iniciales" => "D" "apellidos" => "Sánchez-Aguilar" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] ] ] 3 => array:3 [ "Iniciales" => "J" "apellidos" => "Tor" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Departamento de Dermatología. Complejo Hospitalario Universitario. Facultad de Medicina. Santiago de Compostela. La Coruña. España." "etiqueta" => "a" "identificador" => "affa" ] ] ] ] "pdfFichero" => "103v99nSupl.4a13125457pdf001.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec551616" "palabras" => array:1 [ 0 => "infliximab, psoriasis grave recalcitrante" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "es" => array:1 [ "resumen" => "En el presente artículo, detallamos nuestra experiencia personal con el anticuerpo TNF-α (factor de necrosis tumoral alfa), infliximab. Se trata de cuatro casos que creemos que ilustran adecuadamente varias de las situaciones con las que nos podemos encontrar en el manejo de pacientes con psoriasis y algunos de los contextos clínicos en los que podemos recurrir a infliximab." ] ] ] "idiomaDefecto" => "es" "url" => "/00017310/00000099000000S4/v0_201507151025/13125457/v0_201507151025/es/main.assets" "Apartado" => array:4 [ "identificador" => "14147" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Actualización del uso de infliximab en dermatología" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/00000099000000S4/v0_201507151025/13125457/v0_201507151025/es/103v99nSupl.4a13125457pdf001.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13125457?idApp=UINPBA000044"]

Actas Dermo-Sifiliográficas

ISSN: 0001-7310

The Official publication of the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermo-Sifiliográficas, founded in 1909, is the oldest monthly medical journals published in Spain. In the year 2006 has been indexed in the Medlinedatabase, and has become a vehicle for expressing the most current Spanish medicine and modern. All articles are subjected to a rigorous process of revision in pairs, and careful editing for literary and scientific style. Together with the classic Original and Clinical Case Study sections, we also include Reviews, Case Diagnoses, and Book Reviews. Dermo-Sifiliográficas is an essential publication for anyone who needs to be current on all aspects of Spanish and world dermatology.

Con su JCI 2023, Actas Dermo-Sifiliográficas es Q1 y se posiciona la revista nº 15 de 94 en Dermatología

With JCI 2023, Actas Dermo-Sifiliográficas is Q1 and is ranked number 15 of 94 in Dermatology

Indexed in:

Web of Science, Emerging Sources Citation Index (WoS, Clarivate), PubMed/Medlinee, IME, Embase/Excerpta Medica, Embase, Toxline, Cab Abstracts, Cab Health, Cancerlit NIm, Serline: Biomed, Bibliomed, Pascal, Scopus , IBECS

En el presente artículo, detallamos nuestra experiencia personal con el anticuerpo TNF-α (factor de necrosis tumoral alfa), infliximab. Se trata de cuatro casos que creemos que ilustran adecuadamente varias de las situaciones con las que nos podemos encontrar en el manejo de pacientes con psoriasis y algunos de los contextos clínicos en los que podemos recurrir a infliximab.

Palabras clave:

infliximab, psoriasis grave recalcitrante

Full text is only aviable in PDF